Kangmai Medical Health Care Company has cooperated with China Medical Devices Industry Association, China Ozone Industry Association, China Reproductive Health Industry Association, Nanjing Botanical Research Institute of Chinese Academy of Sciences, International Institute of Chinese Medicine, Zhuhai Yupintang Nourishing Food Research Institute, China Food Fermentation Research Institute, Hong Kong Kotai Pharmaceutical Group, Shanghai Litong Group, Guangdong Kangyuan Pharmaceutical and other units to operate and manage reproductive health, Reproductive beauty, intimate maintenance program, "care for women, attention to reproductive health" as a corporate responsibility.
Jiangsu Institute of Botany, Chinese Academy of Sciences is the only one in East China, and the five major botanical research institutes of the country focus on the research of medicinal values of national scientific research institutions, over the past 50 years, hosted and participated in the country's successive major botanical resources census, accumulated a large number of traditional folk medicine and experience, so that the development of the product has a full of theoretical and practical basis, and the level of phytochemistry to ensure the quality and stability of the product, and the high level of phytochemistry to ensure the quality and stability of the product. The high level of phytochemical research ensures the quality and stability of the products.
International Chinese Medical Research Institute, English name: INT'L CHINA MEDLCNE ACADEME (English abbreviation: ICMAD). ICMAD is relying on the Ministry of Health, the State Administration of Traditional Chinese Medicine, the relevant industry associations (associations) resource advantages at home and abroad in the relevant departments of the old leaders, experts, scholars, enterprises, and the establishment of the support of the Ministry of Health, the State Administration of Traditional Chinese Medicine, the relevant industry associations (associations), the Ministry of Health, the State Administration of Traditional Chinese Medicine, the relevant departments at home and abroad. ICMAD is an international scientific research institution established with the support of the Ministry of Health, the State Administration of Traditional Chinese Medicine, and the relevant industry associations (associations), and with the support of the relevant functional departments, experts, scholars, and enterprises at home and abroad, ICMAD's purpose is to promote medical culture, promote scientific research and development of the industry, and to promote the health of human beings. The main work is: to help enterprises to do product quality control and scientific research, to assist domestic Chinese medicine products in the international service and consultation, to organize key Chinese medicine and health care research and technological research, and to promote scientific and technological achievements. ICMAD specializes in providing technical services for enterprises, solving technical problems, reporting and approving product approvals, carrying out promotional supervision of products, and focusing on international exchanges and cooperation between scientific research institutes and production enterprises, in order to promote the transformation of global pharmaceutical and healthcare research results and help enterprises improve the level of science and technology. ICMAD is giving full play to its advantages under the strong support of leaders and enterprises in the domestic pharmaceutical and health care industry, and is making new contributions to the international development of the Chinese medicine and health care industry and the promotion of the health of all mankind!
Foshan City Medicine and Health Products Industry Association was approved by the Foshan City Civil Affairs Bureau on January 18, 2008 to establish. Its business guidance is the Foshan City Bureau of Economy and Trade and the Foshan City Food and Drug Administration. The association aims to: abide by the Constitution, laws, regulations and national policies, abide by social morality; transfer information, exchange experience, research issues; service enterprises, safeguard the rights and interests of the industry to promote the development of the industry and contacts, and to contribute to the development of the pharmaceutical and health care industry.